期刊
ALLERGY
卷 69, 期 12, 页码 1689-1695出版社
WILEY-BLACKWELL
DOI: 10.1111/all.12518
关键词
allergic rhinoconjunctivitis; minimally important difference; symptom score
资金
- MSD Schering-Plough
- GlaxoSmithKline
- AstraZeneca
- ALK
- Meda Pharma
- Stallergenes
- Phadia-Thermo-Fisher
BackgroundThe minimally important difference (MID) has been defined as the smallest improvement considered worthwhile by a patient. The MID has not been estimated for the Rhinoconjunctivitis Total Symptom Score (RTSS). MethodsIn a prospective multicentre study, patients consulting for grass-pollen-induced allergic rhinitis (AR) recorded a 15-point global rating of change scale (GRCS) score and the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) score on a weekly basis and the individual symptom scores comprising the RTSS on a daily basis over two consecutive weeks. The MID in the RTSS was determined with anchor-based methods (using the GRCS and the RQLQ) and a distribution-based method [based on the RTSS' standard deviation (SD)]. ResultsThe study population comprised 806 patients (253 children, 250 adolescents and 303 adults). During the first week of the study, the meanSD RTSSs for these age groups were 6.5 +/- 3.3, 6.8 +/- 3.4 and 7.0 +/- 3.4, respectively. For an improvement of 2 points in the GRCS or 0.5 points in the RQLQ score, the regression analysis yielded MIDs in the RTSS of 1.24 +/- 0.17 and 1.12 +/- 0.14 in children, 1.33 +/- 0.14 and 1.20 +/- 0.13 in adolescents and 1.13 +/- 0.14 and 0.89 +/- 0.12 in adults, respectively. When applying distribution-based methods, the MID ranged from 1.09 to 1.13 (based on 0.33 SDs of the first-week RTSS) and from 1.22 to 1.40 (based on 0.5 SDs of the difference in RTSSs between the first and second weeks). ConclusionThe MID in the RTSS was consistently estimated as 1.1-1.3 (and could conceivably be rounded to 1) in patients with grass-pollen-induced AR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据